Innovation Industries
Harm de Vries is a seasoned venture capital professional and legal expert with extensive experience in the deep tech and life sciences sectors. As co-founder and General Partner at Innovation Industries since January 2017, Harm focuses on investing in innovative companies that tackle critical global challenges. Prior experience includes co-founding and leading multiple funds such as the Twente Technology Fund, Life Sciences Fund Amsterdam, and Erasmus MC Biomedical Fund, where Harm was integral in supporting various successful investments. Additionally, Harm served as General Counsel at LSP and worked as an Attorney at Law at Hogan Lovells earlier in the career. Harm holds a Master's degree in Business Law from Erasmus University Rotterdam and completed secondary education at Lorentz Lyceum Eindhoven.
This person is not in any teams
This person is not in any offices
Innovation Industries
Innovation Industries is a Dutch deep tech venture capital firm. We invest in deep tech companies with ground-breaking technologies that can address the fundamental challenges of our time. Our portfolio companies are delivering real impact in their industries, ranging from climate-resilient vegetable seeds to safer and more efficient batteries. We are committed to catalysing positive change in the world, which is why we only invest in companies that support one or more environmental, social and/or corporate governance (ESG) goals. Overall impact is important to us, so we focus on both late-stage startups as well as early-stage founders who are making a difference. We are technology enthusiasts with decades of experience in (bio)physics, physiology, chemistry, engineering, and more. We take a hands-on approach to investing, where we act as not only a financial investor but also a business partner, actively supporting our portfolio in reaching their growth and impact goals. Active since 2000, we are the most experienced deep-tech VC firm in the Netherlands and have become a leading player in the Benelux region. We have 20+ years of partnership with key research institutes and experts that support our portfolio.